Beijing (AFP) - A Chinese court on Friday fined British drugmaker GlaxoSmithKline 3.0 billion yuan ($490 million) following a nearly year-long bribery probe, state media said.The fine, levied by the Changsha Intermediate People's Court after a closed hearing in central China's Hunan province, was the largest such penalty ever, China's official Xinhua news agency reported.Chinese authorities had accused GSK employees of bribing hospitals, doctors and health institutions to gain billions of dollars in illegal revenue.Join the conversation about this story »

BING NEWS:
  • GSK strikes £1.1bn deal for asthma drugmaker
    Aiolos licences AIO-001 for use outside China from Jiangsu Hengrui Pharmaceuticals and GSK is effectively buying the licence from Aiolos.
    01/9/2024 - 12:41 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News